Section 4: Clinical Pharmacy Services

4CPS-061

EXTENDED INFUSION OF MEROPENEM IN A NEONATE WITH COMPLICATED KLEBSIELLA PNEUMONIAE MENINGITIS

4CPS-060

PREVALENCE OF VANCOMYCIN-RELATED NEUTROPAENIA, THROMBOCYTOPAENIA AND ACUTE KIDNEY INJURY

4CPS-059

EFFECTIVENESS OF MEROPENEM TREATMENT IN CRITICAL PATIENTS: PHARMACOKINETIC STUDY

4CPS-058

AVOID SIMULTANEUS PRESCRIPTION BETWEEN LINEZOLID AND VORICONAZOLE: PHARMACOKINETIC STUDY

4CPS-057

HOW WELL IS THE TARGET CONCENTRATION OF VANCOMYCIN ACHIEVED IN INTENSIVE CARE UNIT PATIENTS?

4CPS-056

MAPPING ANTIBIOTIC USE PATTERNS IN A SEPTIC ORTHOPAEDIC WARD

4CPS-055

EFFICACY AND SAFETY OF ARTEMISININE DERIVATIVES IN THE TREATMENT OF MALARIA

4CPS-054

USE OF ANTIMICROBIAL AGENTS IN THE EMERGENCY DEPARTMENT IN A THIRD-LEVEL HOSPITAL

4CPS-053

STUDY ON DAPTOMYCIN USE AS A FIRST STEP TOWARDS AN ANTIMICROBIAL STEWARDSHIP PROGRAMME

4CPS-052

FROM THE SURVEILLANCE OF ANTIBIOTICS PRESCRIPTIONS TO LIMITATION OF MULTIDRUG RESISTANT BACTERIA STRAINS: THE ROLE OF THE HOSPITAL PHARMACY IN DEFINING A CARBAPENEM-SPARING-STRATEGY

4CPS-051

ABSTRACT WITHDRAWN

4CPS-050

ANALYSIS OF ANTIBIOTIC ADMINISTRATION IN SURGICAL PROPHYLAXIS

4CPS-049

CEFTOBIPROLE IN EMPIRICAL TREATMENT OF BONE AND JOINT INFECTIONS: SURVEY OF THE PRESCRIPTIONS, RESPECT OF THE PROTOCOL AND ECONOMIC EVALUATION OVER 6 MONTHS

4CPS-048

QUALITY OF THE EMPIRIC ANTIBIOTIC TREATMENT IN COMMUNITY-ACQUIRED PNEUMONIA

4CPS-047

FEASIBILITY OF PHARMACY FOLLOW-UP OF ANTIBIOTIC RE-EVALUATION IN A UNIVERSITY HOSPITAL: DAY-2 OR/AND DAY-7?

Pages